Advanced Medical Optics, Inc. (AMO) (NYSE: EYE) is a global medical device leader focused on the discovery and delivery of innovative vision technologies that optimize the quality of life for people of all ages. The company focuses on developing a broad suite of innovative technologies and devices to address a wide range of eye disorders.
AMO became an independent company in June 2002 following a spin-off from Allergan, Inc. AMO is based in Santa Ana, California, and employs approximately 3,600 people worldwide. The company has operations in 24 countries and markets products in approximately 60 countries.
AMO (originally American Medical Optics) started business in 1976 as a pioneer in the early development of intraocular lenses for cataract patients. We brought the first small-incision foldable intraocular lens through the U. S. Food and Drug Administration (FDA) regulatory process and began marketing it in 1989. Foldable lenses were a major advance in cataract surgery
